A
Aminah Jatoi
Researcher at Mayo Clinic
Publications - 440
Citations - 15796
Aminah Jatoi is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 46, co-authored 404 publications receiving 12708 citations. Previous affiliations of Aminah Jatoi include University of Texas Health Science Center at San Antonio & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Definition and classification of cancer cachexia: an international consensus
Kenneth C. H. Fearon,Florian Strasser,Stefan D. Anker,Ingvar Bosaeus,Eduardo Bruera,Robin L. Fainsinger,Aminah Jatoi,Charles L. Loprinzi,Neil MacDonald,Giovanni Mantovani,Mellar P. Davis,Maurizio Muscaritoli,Faith D. Ottery,Lukas Radbruch,Paula Ravasco,Declan Walsh,Andrew Wilcock,Stein Kaasa,Vickie E. Baracos +18 more
TL;DR: A framework exists on a framework for the definition and classification of cancer cachexia, a multifactorial syndrome defined by an ongoing loss of skeletal muscle mass that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment.
Journal ArticleDOI
Cachexia: a new definition.
William J. Evans,John E. Morley,Josep M. Argilés,Connie W. Bales,Vickie E. Baracos,Denis Guttridge,Aminah Jatoi,Kamyar Kalantar-Zadeh,H. Lochs,Giovanni Mantovani,Daniel L. Marks,William E. Mitch,Maurizio Muscaritoli,Armine Najand,Piotr Ponikowski,Filippo Rossi Fanelli,Morrie Schambelan,Annemie M. W. J. Schols,Michael W. Schuster,David R. Thomas,Robert R. Wolfe,Stefan D. Anker +21 more
TL;DR: The prominent clinical feature of cachexia is weight loss in adults (corrected for fluid retention) or growth failure in children (excluding endocrine disorders).
Journal ArticleDOI
Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study
Aminah Jatoi,Harold E. Windschitl,Charles L. Loprinzi,Jeff A. Sloan,S. R. Dakhil,James A. Mailliard,Sarode Pundaleeka,Carl G. Kardinal,Tom R. Fitch,James E. Krook,Paul J. Novotny,Brad Christensen +11 more
TL;DR: In the doses and schedules studied, megestrol acetate provided superior anorexia palliation among advanced cancer patients compared with dronabinol alone, and an improvement in quality of life (QOL) among megestro acetate-treated and combination-treated patients.
Journal ArticleDOI
Sarcopenia: A Time for Action. An SCWD Position Paper.
Juergen M. Bauer,John E. Morley,Annemie M. W. J. Schols,Luigi Ferrucci,Alfonso J. Cruz-Jentoft,Elsa Dent,Vickie E. Baracos,Jeffrey Crawford,Wolfram Doehner,Steven B. Heymsfield,Aminah Jatoi,Kamyar Kalantar-Zadeh,Mitja Lainscak,Francesco Landi,Francesco Landi,Alessandro Laviano,Michelangelo Mancuso,Maurizio Muscaritoli,Carla M. Prado,Florian Strasser,Stephan von Haehling,Andrew J.S. Coats,Stefan D. Anker +22 more
TL;DR: It is important to address the risk factors for sarcopenia, particularly low physical activity and sedentary behavior in the general population, using a life‐long approach.
Journal ArticleDOI
Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
Shontelle Dodson,Vickie E. Baracos,Aminah Jatoi,William J. Evans,David Cella,James T. Dalton,Mitchell S. Steiner +6 more
TL;DR: Several agents are in clinical development, including anabolic agents, such as selective androgen receptor modulators and drugs targeting inflammatory cytokines that promote skeletal muscle catabolism that promote muscle mass and physical performance.